Postnatal anxiety estimates vary substantially because studies measure different populations, postpartum windows, symptoms, and clinical thresholds. Across the available evidence, reported anxiety ranges from single-digit estimates for diagnosed anxiety disorders to more than one-quarter of participants meeting symptom-screening thresholds.
Contents
- How common is postnatal anxiety?
- How anxiety changes during the first postpartum year
- Differences by age, birthplace, and household circumstances
- Mental-health history and pregnancy factors
- Support, mood, and pregnancy-related care
- Birth experience and early infant factors
How common is postnatal anxiety?
The World Health Organization’s 2023 summary of postpartum health evidence reports anxiety affecting 9%–24% of postpartum women across the cited studies. This is a literature range rather than one survey result, so it should not be treated as a single worldwide prevalence estimate. World Health Organization
In a population-based survey of women who gave birth in Illinois and Maryland during 2009–2010, 18.0% reported anxiety symptoms. In the same survey, 6.3% of all postpartum women reported both anxiety symptoms and depressive symptoms. Postpartum Anxiety and Comorbid Depression in a Population-Based Sample of Women
A 2025 study of 820 postpartum women in Spain used the GAD-7 screening questionnaire and reported three severity bands:
| GAD-7 screening range | Share of participants | Measurement period |
|---|---|---|
| Mild anxiety | 36.1% | 2025 postpartum assessments |
| Moderate anxiety | 8.5% | 2025 postpartum assessments |
| Severe anxiety | 2.7% | 2025 postpartum assessments |
These are screening categories, not diagnoses. The study’s mild, moderate, and severe percentages should not be added to estimates from other studies that used different thresholds or populations. Prevalence and associated factors of anxiety in postpartum women
During the COVID-19 pandemic, a survey conducted across nine countries found clinically significant anxiety in 26.6% of postpartum participants when the GAD-7 cutoff was 10 or higher. In that same survey, 20.3% met both the study’s clinically significant anxiety and depression cutoffs. The measurement period was June 7 through October 31, 2020, and pandemic conditions may have elevated estimates compared with some pre-pandemic settings. Rates of depressive and anxiety symptoms in the perinatal period during the COVID-19 pandemic
How anxiety changes during the first postpartum year
The French national perinatal surveys reported anxiety symptoms at several points after birth. At 2 months postpartum, 27.6% of women screened positive using the EPDS-3A anxiety subscale, with a threshold of at least 5 out of 9. The corresponding estimates were 21.0% at 6 months and 18.0% at 12 months postpartum. The births were in 2021. Santé mentale des femmes en période périnatale en France en 2021
The EPDS-3A captures anxiety symptoms over the prior week. It is a screening subscale rather than a standalone diagnosis, so these figures describe symptom screening at specific time points. The French data are reported in an official synthesis and in the underlying cohort article; the dates above refer to measurement periods, not publication years.
| Postpartum timing | Anxiety-symptom estimate | Measure and setting |
|---|---|---|
| 2 months | 27.6% | French 2021 births; EPDS-3A ≥5/9 |
| 6 months | 21.0% | French 2021 births |
| 12 months | 18.0% | French 2021 births |
A systematic review and meta-analysis estimated clinical diagnosis of any anxiety disorder at 9.6% during 5–12 weeks postpartum, 9.9% during 1–24 weeks postpartum, and 9.3% beyond 24 weeks postpartum. The review included studies available through 2015. These diagnosis estimates are not interchangeable with the French symptom-screening percentages. Prevalence of antenatal and postnatal anxiety: Systematic review and meta-analysis
Not every longitudinal sample shows the same pattern. In a pre-vaccine COVID-19 pandemic peripartum cohort, 10.0% had elevated anxiety symptoms at 6–8 weeks postpartum, compared with 17.3% by 6 months postpartum. This difference illustrates why timing, context, and sample design matter when comparing results. Patterns of peripartum depression and anxiety during the pre-vaccine COVID-19 pandemic
Differences by age, birthplace, and household circumstances
The French 2021 national cohort reported anxiety symptoms by maternal characteristics at 2 months postpartum. Among mothers aged 15–24 years, 32.2% screened positive; the estimate was 31.4% for ages 25–29, 26.8% for ages 30–34, 22.0% for ages 35–39, and 24.6% for ages 40 or older.
Birthplace categories also differed in that cohort. Anxiety symptoms affected 27.0% of women born in France, 29.1% of women born in North Africa, 32.6% of women born in other African countries, and 33.4% of women in the study’s category for women born outside France, Europe, North Africa, or the other-African-country category.
Living arrangements and education showed additional variation. At 2 months postpartum, symptoms were reported by 31.5% of women not living with a partner and 28.6% of mothers without a secondary-school diploma. The estimate was 27.4% among mothers with a secondary-school diploma plus 1 or 2 years of tertiary education.
These percentages are subgroup descriptions from one French cohort, not universal risk levels for every age, birthplace, relationship, or education group. They also do not show that any listed characteristic causes anxiety.
Mental-health history and pregnancy factors
Household income was associated with different symptom percentages in the French cohort. At 2 months postpartum, anxiety symptoms affected 30.4% of women with monthly household income below €1,500, 28.4% of those with income of €1,500–€2,900, and 26.4% of those with income of at least €3,000.
The French adjusted model found that each one-point increase in the health-literacy difficulty score was associated with an adjusted prevalence ratio of 1.15 for postnatal anxiety symptoms. This is an association from an adjusted observational model; it is not a measure of individual probability or proof of causation.
Mental-health-care history showed some of the largest subgroup differences reported in the French data. Anxiety symptoms affected 25.9% of women with no mental-health-care history since adolescence, 35.8% of women with at least 3 months of prior psychological care, and 40.8% of women with at least 3 months of prior psychiatric care or psychiatric hospitalization. The estimate was 36.3% among women with a history of medical termination of pregnancy.
Pregnancy and parity variables also varied. Symptoms affected 31.4% of women who were nulliparous. The estimate was 38.4% among women who gained no pregnancy weight or lost weight, 26.2% among those who gained 9–15 kg, and 35.2% among those who gained at least 23 kg.
The study design supports describing these as correlates observed at 2 months postpartum. It does not establish that income, health literacy, previous care, pregnancy history, parity, or weight change directly causes postnatal anxiety.
Support, mood, and pregnancy-related care
Pregnancy-related emergency or walk-in consultations were associated with different anxiety-symptom percentages in the French cohort. At 2 months postpartum, symptoms affected 25.0% of women with no such consultation, 31.8% of women with two consultations, and 36.9% of women with at least three consultations.
Perceived support from loved ones during pregnancy also showed a clear gradient in the reported percentages. Anxiety symptoms affected 36.6% of women who reported little or no support, 30.5% of women who reported good support, and 25.1% of women who reported very good support.
The same French data linked prenatal mood symptoms with higher postpartum anxiety screening percentages. Among women who experienced sadness, despair, or hopelessness for at least 2 weeks during pregnancy, 35.3% screened positive for anxiety symptoms at 2 months postpartum. The estimate was 34.5% among women who experienced anhedonia for at least 2 weeks.
The highest percentage in this group was 47.7% among women who experienced both sadness and anhedonia during pregnancy. By comparison, 21.5% of women who reported neither sadness nor anhedonia screened positive. These results describe overlapping observational groups and should not be read as a prediction for an individual parent.
Birth experience and early infant factors
Anxiety-symptom percentages also differed by reported mode of delivery in the French cohort. At 2 months postpartum, symptoms affected 26.6% after spontaneous vaginal delivery, 30.9% after instrumental vaginal delivery, and 27.2% after scheduled cesarean delivery.
Satisfaction with pain management was another reported correlate: 32.2% of women who were not at all or not very satisfied with childbirth pain management screened positive. Among women who received combined epidural, spinal, or perirachial anesthesia, the estimate was 27.9%.
Infant-related measures were associated with the following percentages at 2 months postpartum:
- 33.1% among mothers whose infants were born preterm, defined as before 37 weeks.
- 30.1% among mothers whose infants were small for gestational age.
- 32.6% among mothers whose infants were hospitalized during the first 2 months after maternity discharge.
Taken together, these findings show why postnatal anxiety statistics need context. A diagnosis estimate, a symptom-screening percentage, and a severity-band result answer different questions. The relevant country, birth cohort, postpartum timing, instrument, cutoff, and pandemic context should accompany every number. The available risk-factor results are observational associations, not clinical advice or causal conclusions.